Economy

Money multiplier stocks of the day: Alexion Pharmaceuticals, Inc. (ALXN)

ALXN's profit will be $252.20M for 31.23 P/E if the $1.13 EPS becomes a reality. After having $0.25 EPS previously, Crawford & Company's analysts see -12.00% EPS growth. The total number of shares traded in the last 90-day period is 17,190. Diageo plc (ADR) (NYSE:DEO) has risen 12.82% since October 10, 2016 and is uptrending.

Sell-side analyst recommendations point to a short term price target of $163.76 on the shares of Alexion Pharmaceuticals, Inc. ALXN's SI was 5.91M shares in October as released by FINRA. Palo Alto Investors Llc owns 1.03 million shares or 5.86% of their United States portfolio. More interesting news about Alexion Pharmaceuticals, Inc. The total number of shares traded in the last 12 months is 2.42 million.

09/14/2017 - RBC Capital began new coverage on Alexion Pharmaceuticals, Inc. giving the company a "outperform" rating. It has underperformed by 34.82% the S&P500.

Since June 14, 2017, it had 4 insider buys, and 1 sale for $235.75 million activity.

Ratings analysis reveals 78% of Alexion Pharmaceuticals Inc.'s analysts are positive. It improved, as 55 investors sold ALXN shares while 146 reduced holdings. Moreover, Carlson Lp has 0.2% invested in Alexion Pharmaceuticals, Inc. The correct version of this piece can be read at https://www.dispatchtribunal.com/2017/10/09/renaissance-technologies-llc-sells-148642-shares-of-alexion-pharmaceuticals-inc-alxn.html. Of those transactions, there were 2.25 million shares of ALXN bought and 170,623 shares sold. The insider PARVEN ALVIN S sold $97,511.

Investors sentiment increased to 1.37 in Q2 2017. Its up 0.23, from 1.14 in 2017Q1.

Capital Research Global Investors increased its position in Alexion Pharmaceuticals, Inc. 72 funds opened positions while 203 raised stakes. The institutional investor held 116,487 shares of the transportation company at the end of 2017Q2, valued at $8.77 million, down from 121,262 at the end of the previous reported quarter. It also reduced its holding in Lilly Eli & Co (NYSE:LLY) by 255,200 shares in the quarter, leaving it with 3.08M shares, and cut its stake in Merck & Co Inc (NYSE:MRK). Westpac holds 0% or 17,674 shares. Elk Creek Ptnrs has invested 0.03% in Alexion Pharmaceuticals, Inc. Cibc Asset holds 0.02% or 27,520 shares in its portfolio. The fund owned 142,195 shares of the biopharmaceutical company's stock after buying an additional 970 shares during the quarter. Meeder Asset has invested 0.01% in Alexion Pharmaceuticals, Inc. It also shows the how good the amount of profit for (NASDAQ:ALXN) is relative to its total expenditure. Stevens Cap Mgmt Limited Partnership invested in 0.31% or 67,388 shares.

The share price of Alexion Pharmaceuticals, Inc.

The average volume for (NASDAQ:ALXN) is now rolling at 1560.79. Massachusetts Fin Serv Communications Ma invested in 111,437 shares or 0.01% of the stock. The New York-based Orbimed Advisors Llc has invested 4.94% in the stock. Apg Asset Management Nv holds 0.01% or 55,932 shares. Fiduciary Trust owns 912 shares.

Analysts expect Alexion Pharmaceuticals, Inc. Out of 27 Wall Street analysts rating Alexion Pharmaceuticals Inc., 21 give it "Buy", 0 "Sell" rating, while 6 recommend "Hold". Therefore 78% are positive.

05/23/2017 - Alexion Pharmaceuticals, Inc. had its "buy" rating reiterated by analysts at Stifel Nicolaus. The company was maintained on Friday, July 29 by Barclays Capital.

The operating margin of (NASDAQ:ALXN) is valued at 21.80% and the profit margin measures at 15.30%. Stifel Nicolaus has "Buy" rating and $15700 target. (NASDAQ:ALXN) were released by: Seekingalpha.com and their article: "Alexion: Buy On Dips With Soliris Catalyst Upcoming" published on October 08, 2017 as well as Seekingalpha.com's news article titled: "Alexion Pharmaceuticals' (ALXN) CEO Ludwig Hantson Presents at Morgan Stanley ..." with publication date: September 13, 2017. The stock of United Continental Holdings Inc (NYSE:UAL) earned "Overweight" rating by Morgan Stanley on Thursday, April 28.

In other news, Director Ann M. Veneman sold 700 shares of Alexion Pharmaceuticals stock in a transaction on Monday, July 31st. (NASDAQ:ALXN) on Thursday, January 7 to "Neutral" rating. 2,000 shares were bought by COUGHLIN CHRISTOPHER J, worth $234,200 on Thursday, June 15. Finally, OLD Mutual Customised Solutions Proprietary Ltd. boosted its stake in shares of Alexion Pharmaceuticals by 36.1% in the first quarter. FBR Capital has "Mkt Perform" rating and $130 target. Instinet reissued a "buy" rating and issued a $148.00 price target on shares of Alexion Pharmaceuticals in a research report on Thursday, March 30th.

Gideon Cap Advsrs has invested 0.49% of its portfolio in Alexion Pharmaceuticals, Inc. The company has a market capitalization of $22.70 billion, a P/E ratio of 48.16 and a beta of 1.39.



Like this

loading...
loading...

Latest


11 October 2017
Harmanpreet Hits Brace as India Beat Japan in Asia Cup 2017 Opener
This will be the fifth meeting between Pakistan and Bangladesh in Asia Cup. This was the only practice match for the Green-shirts before the Asia Cup.

11 October 2017
Sensex recaptures 32000 mark on global rally; Nifty hovers above 10K
Midcap and smallcap shares were seen outperforming the broader indices in morning deals - up between 0.6 per cent and 0.75 per cent.

11 October 2017
Mukul Roy resigns from Rajya Sabha, keeps suspense about future political move
The meeting between the two leaders comes amid specualations that Roy may join the Bharatiya Janata Party. Only time will tell. "It is a strategical decision known to Mamatadi", Mukul Roy said on his decision.

11 October 2017
US B-1B bombers from Guam drill off SKorea coast
In the past decade, it has been blamed for numerous cyberheists and other hacking attacks in South Korea and elsewhere. North Korea's nuclear weapons program has become the most urgent national security issue during the Trump presidency.

11 October 2017
Anupam Kher replaces Gajendra Chauhan as new FTII chief
Talking about his vast filmography, Anupam Kher had told HT , "In a span of 35 years, I have done 500 films. Anupam Kher replaces Gajendra Chauhan, who had a controversial tenure as head of the Pune-based institute.

11 October 2017
Hunt out of Sydney fight: 'I'll forget something I did yesterday'
I did years and years ago. "I just hope that if it does happen, it will be in an honest and fair competition". I'll forget something I did yesterday but I can remember the s-t I did years and years ago.

11 October 2017
Man United and Chelsea to battle for Rose
Tottenham left back Danny Rose is reportedly setting his sights on a move to Premier League rivals Manchester United next summer. Signing Rose would arguably solve United's problems on the left of defence in one swoop.

11 October 2017
Detroit Officers Suspended Amid Probe Into Deadly High-Speed Chase
She said her and her boyfriend were shopping at Meijer, and when they left, loss protection employees approached them. Detroit Police Chief James Craig is expected to provide more information about this incident later on Wednesday.

11 October 2017
Ozil urged to snub Manchester United and return to Germany
The 28-year-old recently returned to the gym in an aim to regain fitness ahead of this weekend's Premier League clash. It's a really good option because we get another national player back in our league", Riedle added.

11 October 2017
Donald Trump will not meet Queen on downgraded visit
The President is expected to make a "working visit" in 2018 for talks with the Prime Minister instead of meeting the Queen. Downing street has not yet commented on the proposed visit by the controversial president.